PI3K? inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways.
Scientific reports 2015 5 9465.
Feng Chenchen, Sun Yang, Ding Guanxiong, Wu Zhong, Jiang Haowen, Wang Lujia, Ding Qiang, Wen H
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: